| angiotensin II receptor, type 1 | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | AGTR1 | ||||||
| Alt. symbols | AGTR1B | ||||||
| IUPHAR | 34 | ||||||
| NCBI gene | 185 | ||||||
| HGNC | 336 | ||||||
| OMIM | 106165 | ||||||
| RefSeq | NM_000685 | ||||||
| UniProt | P30556 | ||||||
| Other data | |||||||
| Locus | Chr. 3q21-q25 | ||||||
| |||||||
| angiotensin II receptor, type 2 | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Symbol | AGTR2 | ||||||
| IUPHAR | 35 | ||||||
| NCBI gene | 186 | ||||||
| HGNC | 338 | ||||||
| OMIM | 300034 | ||||||
| RefSeq | NM_000686 | ||||||
| UniProt | P50052 | ||||||
| Other data | |||||||
| Locus | Chr. Xq22-q23 | ||||||
| |||||||
Theangiotensin II receptors,(ATR1) and(ATR2), are a class ofG protein-coupled receptors withangiotensin II as theirligands.[1] They are important in therenin–angiotensin system: they are responsible for thesignal transduction of thevasoconstricting stimulus of the main effector hormone,angiotensin II.[2]
TheAT1 andAT2 receptors share a sequence identity of ~30%, but have a similar affinity for angiotensin II, which is their main ligand.
| Receptor | Mechanism[3] |
|---|---|
| AT1 | |
| AT2 | |
| AT3 | |
| AT4 |
The AT1 receptor is the best elucidated angiotensin receptor.
The AT1 subtype is found in the heart, blood vessels, kidney, adrenal cortex, lung andcircumventricular organs of brain,basal ganglia,brainstem[4] and mediates the vasoconstrictor effects.
The angiotensin receptor is activated by thevasoconstricting peptideangiotensin II. The activated receptor in turn couples toGq/11 andGi/o and thus activatesphospholipase C and increases the cytosolic Ca2+ concentrations, which in turn triggers cellular responses such as stimulation ofprotein kinase C. Activated receptor also inhibitsadenylate cyclase and activates varioustyrosine kinases.[2]
Effects mediated by the AT1 receptor includevasoconstriction,aldosterone synthesis and secretion, increasedvasopressin secretion,cardiachypertrophy, augmentation of peripheralnoradrenergic activity,vascularsmooth muscle cells proliferation, decreasedrenal blood flow, renalrenin inhibition, renal tubularsodium reuptake, modulation of centralsympathetic nervous system activity, cardiac contractility, centralosmocontrol andextracellular matrix formation.[5]
AT2 receptors are more plentiful in the fetus and neonate. The AT2 receptor remains enigmatic and controversial – is probably involved in vascular growth. Effects mediated by the AT2 receptor are suggested to include inhibition ofcell growth, fetal tissue development, modulation of extracellular matrix,neuronal regeneration,apoptosis,cellular differentiation, and maybevasodilation andleft ventricular hypertrophy.[6] In humans the AT2 subtype is found in molecular layer of thecerebellum. In the mouse is found in the adrenal gland, amygdaloid nuclei and, in small numbers, in the paraventricular nucleus of the hypothalamus and the locus coeruleus.[7]
Other poorly characterized subtypes include the AT3 and AT4 receptors. The AT4 receptor is activated by the angiotensin II metaboliteangiotensin IV, and may play a role in regulation of the CNS extracellular matrix, as well as modulation ofoxytocin release.[8][9][10]